-+ 0.00%
-+ 0.00%
-+ 0.00%

TD Cowen Maintains Buy on Helus Pharma, Raises Price Target to $62

Benzinga·08/20/2026 14:20:21
語音播報
TD Cowen analyst Ritu Baral maintains Helus Pharma (NASDAQ:HELP) with a Buy and raises the price target from $8 to $62.